Yair Mina1, Tianxia Wu1, Hsing-Chuan Hsieh1, Dima A Hammoud1, Swati Shah1, Chuen-Yen Lau1, Lillian Ham1, Joseph Snow1, Elizabeth Horne1, Anuradha Ganesan1, Stanley I Rapoport1, Edmund C Tramont1, Daniel S Reich1, Brian K Agan1, Avindra Nath1, Bryan R Smith2. 1. From the National Institute of Neurological Disorders and Stroke (Y.M., T.W., E.H., D.S.R., A.N., B.R.S.), Center for Infectious Disease Imaging, Radiology and Imaging Sciences, Clinical Center (D.A.H., S.S.), National Institute of Allergy and Infectious Diseases (C.-Y.L., E.C.T.), National Institute of Mental Health (L.H., J.S.), and National Institute on Alcohol Abuse and Alcoholism (S.I.R.), National Institutes of Health, Bethesda, MD; Sackler Faculty of Medicine (Y.M.), Tel Aviv University, Israel; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics (H.-C.H., A.G., B.K.A.), Uniformed Services University of the Health Sciences; and Henry M. Jackson Foundation for the Advancement of Military Medicine Inc. (H.-C.H., A.G., B.K.A.), Bethesda, MD. 2. From the National Institute of Neurological Disorders and Stroke (Y.M., T.W., E.H., D.S.R., A.N., B.R.S.), Center for Infectious Disease Imaging, Radiology and Imaging Sciences, Clinical Center (D.A.H., S.S.), National Institute of Allergy and Infectious Diseases (C.-Y.L., E.C.T.), National Institute of Mental Health (L.H., J.S.), and National Institute on Alcohol Abuse and Alcoholism (S.I.R.), National Institutes of Health, Bethesda, MD; Sackler Faculty of Medicine (Y.M.), Tel Aviv University, Israel; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics (H.-C.H., A.G., B.K.A.), Uniformed Services University of the Health Sciences; and Henry M. Jackson Foundation for the Advancement of Military Medicine Inc. (H.-C.H., A.G., B.K.A.), Bethesda, MD. bryan.smith2@nih.gov.
Abstract
OBJECTIVE: To test the hypothesis that brain white matter hyperintensities (WMH) are more common in people living with HIV (PLWH), even in the setting of well-controlled infection, and to identify clinical measures that correlate with these abnormalities. METHODS: Research brain MRI scans, acquired within longitudinal studies evaluating neurocognitive outcomes, were reviewed to determine WMH load using the Fazekas visual rating scale in PLWH with well-controlled infection (antiretroviral therapy for at least 1 year and plasma viral load <200 copies/mL) and in sociodemographically matched controls without HIV (CWOH). The primary outcome measure of this cross-sectional analysis was increased WMH load, determined by total Fazekas score ≥2. Multiple logistic regression analysis was performed to evaluate the effect of HIV serostatus on WMH load and to identify MRI, CSF, and clinical variables that associate with WMH in the PLWH group. RESULTS: The study included 203 PLWH and 58 CWOH who completed a brain MRI scan between April 2014 and March 2019. The multiple logistic regression analysis, with age and history of tobacco use as covariates, showed that the adjusted odds ratio of the PLWH group for increased WMH load is 3.7 (95% confidence interval 1.8-7.5; p = 0.0004). For the PLWH group, increased WMH load was associated with older age, male sex, tobacco use, hypertension, and hepatitis C virus coinfection, and also with the presence of measurable tumor necrosis factor α in CSF. CONCLUSION: Our results suggest that HIV serostatus affects the extent of brain WMH. This effect is mainly associated with aging and modifiable comorbidities.
OBJECTIVE: To test the hypothesis that brain white matter hyperintensities (WMH) are more common in people living with HIV (PLWH), even in the setting of well-controlled infection, and to identify clinical measures that correlate with these abnormalities. METHODS: Research brain MRI scans, acquired within longitudinal studies evaluating neurocognitive outcomes, were reviewed to determine WMH load using the Fazekas visual rating scale in PLWH with well-controlled infection (antiretroviral therapy for at least 1 year and plasma viral load <200 copies/mL) and in sociodemographically matched controls without HIV (CWOH). The primary outcome measure of this cross-sectional analysis was increased WMH load, determined by total Fazekas score ≥2. Multiple logistic regression analysis was performed to evaluate the effect of HIV serostatus on WMH load and to identify MRI, CSF, and clinical variables that associate with WMH in the PLWH group. RESULTS: The study included 203 PLWH and 58 CWOH who completed a brain MRI scan between April 2014 and March 2019. The multiple logistic regression analysis, with age and history of tobacco use as covariates, showed that the adjusted odds ratio of the PLWH group for increased WMH load is 3.7 (95% confidence interval 1.8-7.5; p = 0.0004). For the PLWH group, increased WMH load was associated with older age, male sex, tobacco use, hypertension, and hepatitis C virus coinfection, and also with the presence of measurable tumor necrosis factor α in CSF. CONCLUSION: Our results suggest that HIV serostatus affects the extent of brain WMH. This effect is mainly associated with aging and modifiable comorbidities.
Authors: Talia N Shirazi; Angela C Summers; Bryan R Smith; Sally R Steinbach; Suad Kapetanovic; Avindra Nath; Joseph Snow Journal: AIDS Behav Date: 2017-07
Authors: Nancy A West; B Gwen Windham; David S Knopman; Dean K Shibata; Laura H Coker; Thomas H Mosley Journal: Neurology Date: 2019-01-18 Impact factor: 9.910
Authors: Lachlan R Gray; Michael Roche; Jacqueline K Flynn; Steve L Wesselingh; Paul R Gorry; Melissa J Churchill Journal: Curr Opin HIV AIDS Date: 2014-11 Impact factor: 4.283
Authors: Zoe Morris; William N Whiteley; W T Longstreth; Frank Weber; Yi-Chung Lee; Yoshito Tsushima; Hannah Alphs; Susanne C Ladd; Charles Warlow; Joanna M Wardlaw; Rustam Al-Shahi Salman Journal: BMJ Date: 2009-08-17
Authors: Mohamad Habes; Aristeidis Sotiras; Guray Erus; Jon B Toledo; Deborah Janowitz; David A Wolk; Haochang Shou; Nick R Bryan; Jimit Doshi; Henry Völzke; Ulf Schminke; Wolfgang Hoffmann; Susan M Resnick; Hans J Grabe; Christos Davatzikos Journal: Neurology Date: 2018-08-03 Impact factor: 9.910
Authors: Rosan A van Zoest; Jonathan Underwood; Davide De Francesco; Caroline A Sabin; James H Cole; Ferdinand W Wit; Matthan W A Caan; Neeltje A Kootstra; Dietmar Fuchs; Henrik Zetterberg; Charles B L M Majoie; Peter Portegies; Alan Winston; David J Sharp; Magnus Gisslén; Peter Reiss Journal: J Infect Dis Date: 2017-12-27 Impact factor: 5.226
Authors: Tanja Su; Ferdinand W N M Wit; Matthan W A Caan; Judith Schouten; Maria Prins; Gert J Geurtsen; James H Cole; David J Sharp; Edo Richard; Liesbeth Reneman; Peter Portegies; Peter Reiss; Charles B Majoie Journal: AIDS Date: 2016-09-24 Impact factor: 4.177
Authors: Jason G van Genderen; Cecilia Chia; Malon Van den Hof; Henk J M M Mutsaerts; Liesbeth Reneman; Dasja Pajkrt; Anouk Schrantee Journal: Neurology Date: 2022-08-08 Impact factor: 11.800